ENTITY
Burning Rock Biotech

Burning Rock Biotech (BNR US)

41
Analysis
Health CareChina
Burning Rock Biotech Limited operates as a biotech company. The Company discovers and develops diagnositcs solutions for precision medicine in oncology. Burning Rock Biotech serves customers in China.
more
Refresh
21 Feb 2024 21:55

Genetron (GTH US): Wide Spread Ahead of the 21 February Vote

Shareholders overwhelmingly approve the privatisation proposal. Turnout was at 75.4% of outstanding shares. Among these shareholders, 99.9% voted...

Logo
643 Views
Share
bearishGenecast Group
16 Nov 2023 08:55

Pre-IPO Genecast Group - NGS Still Has Long Way to Go; Valuation Performance Is Worrying

Genecast’s business faces different challenges as NGS hasn't developed as rigid demand. It's difficult for Genecast to make profits in the short...

Logo
297 Views
Share
01 Sep 2022 19:19

Burning Rock Biotech (BNR US): Despite Q2 Results Missing Consensus Management Reiterated Guidance

Burning Rock’s Q2 results were negatively impacted by COVID-related restrictions in China. However, management reiterated 2022 guidance, indicating...

Logo
249 Views
Share
03 Aug 2022 09:12

Industry Report - Insights on China Companion Diagnostics Market (Business Logic and Outlook)

As targeted drug price fall, logic of companion diagnosis will go from "To C" to "To B".Despite challenges,NGS will be the future trend. A “good...

Logo
222 Views
Share
02 Jun 2022 17:43

Burning Rock Biotech (BNR US) 1Q22: Double-Digit Revenue Growth; China Re-Opening to Boost Recovery

Despite COVID impact, Burning Rock started 2022 on a strong note, with accelerated double-digit revenue growth, driven by testing volume. With...

Logo
323 Views
Share
x